Shares of WisdomTree U.S. MidCap Dividend Fund (NYSEARCA:DON – Get Free Report) reached a new 52-week high during mid-day trading on Tuesday . The stock traded as high as $51.30 and last traded at $51.30, with a volume of 6234 shares. The stock had previously closed at $51.03.
WisdomTree U.S. MidCap Dividend Fund Price Performance
The firm has a market cap of $3.83 billion, a PE ratio of 12.48 and a beta of 0.95. The stock has a 50-day moving average price of $49.09 and a 200 day moving average price of $47.91.
Institutional Inflows and Outflows
Several large investors have recently modified their holdings of the stock. LifeSteps Financial Inc. purchased a new position in WisdomTree U.S. MidCap Dividend Fund during the first quarter worth approximately $26,000. International Assets Investment Management LLC purchased a new position in shares of WisdomTree U.S. MidCap Dividend Fund in the 2nd quarter worth about $26,000. Ashton Thomas Private Wealth LLC acquired a new position in shares of WisdomTree U.S. MidCap Dividend Fund in the 2nd quarter valued at about $40,000. New Covenant Trust Company N.A. acquired a new stake in WisdomTree U.S. MidCap Dividend Fund during the 1st quarter worth approximately $68,000. Finally, Massmutual Trust Co. FSB ADV purchased a new position in WisdomTree U.S. MidCap Dividend Fund in the first quarter valued at approximately $71,000.
WisdomTree U.S. MidCap Dividend Fund Company Profile
WisdomTree MidCap Dividend Fund (the Fund) seeks investment results that closely correspond to the price and yield performance of the WisdomTree MidCap Dividend Index (the Index). The Index is a fundamentally weighted index that measures the performance of the mid-capitalization segment of the United States dividend-paying market.
Featured Stories
- Five stocks we like better than WisdomTree U.S. MidCap Dividend Fund
- Are Penny Stocks a Good Fit for Your Portfolio?
- Biohaven Stock Soars on Drug Trial Results: Time to Jump In?
- The Significance of Brokerage Rankings in Stock Selection
- Is AMD a Legitimate Threat to NVIDIA? What Investors Should Watch
- How the NYSE and NASDAQ are Different, Why That Matters to Investors
- Novo Nordisk’s Setback Won’t Last: A Game-Changing Drug Emerges
Receive News & Ratings for WisdomTree U.S. MidCap Dividend Fund Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for WisdomTree U.S. MidCap Dividend Fund and related companies with MarketBeat.com's FREE daily email newsletter.